IL1B and dry eye syndrome: The current study confirms that topical fluorometholone significantly decreases the protein expression of TNF-α and IL-1β on corneal and conjunctival epithelia in the Botulium toxin B-induced dry eye mouse model, consistent with improved corneal fluorescein staining, but without the significant change in tear production.